SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+13.9%
5Y CAGR+10.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+13.9%/yr
vs +1.0%/yr prior
5Y CAGR
+10.4%/yr
Recent acceleration
Acceleration
+13.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$31.54B+0.8%
2024$31.28B+35.5%
2023$23.08B+8.2%
2022$21.33B+1.4%
2021$21.03B+9.2%
2020$19.25B+0.6%
2019$19.13B-6.8%
2018$20.52B-4.4%
2017$21.46B-3.5%
2016$22.24B-